Davis Vision competitors

Martha, the 8th president and CEO of Blue Cross & Blue Shield of Rhode Island, has been a recognized leader in healthcare since 2005. Martha came to Blue Cross from DaVita, where for almost seven years she led the company’s critical shift from volume to value-based care, taking full financial and clinical accountability for kidney patients on behalf of commercial payers. Martha also oversaw patient experience and patient education at DaVita’s 2800 dialysis clinics nationwide. Prior to joining DaVita, Martha worked at Aetna for nearly a decade in various leadership roles. She led the company’s effort to deliver simple solutions to help consumers navigate the healthcare system. Martha helped to start up Aetna’s Medicare Advantage and prescription drug plan business; was responsible for Aetna’s national direct-to-consumer sales capability; and served as the general manager for the Northeast Region for Aetna’s Medicare and consumer segment, with full accountability for more than a billion dollars in P&L. Martha was a consultant with Booz Allen Hamilton from 2000 to 2005, focusing on growth strategies in the healthcare and media industries. She served in the Clinton Administration for more than six years in communications and legislative positions in The White House, the U.S. Agency for International Development and the U.S. Environmental Protection Agency. Martha earned her M.B.A. from the Kellogg School of Management at Northwestern University, where she focused on strategy and managerial economics, and she received a B.A. in history from Swarthmore College. Martha served as executive director of the Aspen Group for five years, a non-partisan group of healthcare leaders dedicated to developing and promoting meaningful solutions that advance the health and healthcare of all Americans. She cares deeply about access to education and serves on the Kellogg Alumni Council, and recently stepped down from the Denver Scholarship Foundation board of directors, which provides tools, guidance and financial resources to Denver’s public school students to enroll in and graduate from postsecondary institutions of higher education. Martha is passionate about food security and is an active volunteer with community food organizations in Denver.

Mr. Constantine was appointed President and CEO of United Concordia Dental (UCD) in August 2019 after having served as its President and COO since June 2017. UCD is Highmark Inc.'s national dental subsidiary serving approximately 9 million members with annual revenues of approximately $1.6B. Mr. Constantine previously served as Executive Vice President of Commercial Markets for Highmark Inc. from July 2015 until June 2017. Mr. Constantine also served as the President of Highmark Blue Cross Blue Shield Delaware from January 2012 through August 2018. He joined Blue Cross Blue Shield of Delaware (predecessor to Highmark Blue Cross Blue Shield Delaware) in 1998 as Vice President of Network and Medical Management and was appointed President in 2001 and President/CEO in 2006. A Delaware resident for over 25 years, Mr. Constantine has a strong commitment to the state’s businesses and communities. He currently serves as a trustee for Wesley College and is on the Delaware State Chamber of Commerce Board of Governors. Mr. Constantine previously served on the following boards: United Way of Delaware (Chair and Member of Executive Committee); the Delaware Center for Health Innovation; Delaware Business Roundtable; and the Delaware Chapter of the American Heart Association. He is also a member of the University of Delaware's College of Health Sciences Advisory Council. Mr. Constantine served on the Board of Directors of the Blue Cross and Blue Shield Association (BCBSA) from 2006 - 2011 and was Vice Chair of BCBSA's Audit Committee.

Strategic and tactical business leader with a track record of achievement and accomplishment in start-up, growing, developing, and maturing organizations, including divestiture/acquisition. Exceptional record of revenue and profitability growth in the highly regulated health care industry and in technology markets. Recognized for vision, leadership, business development results and ability to create and manage an organization to high-achievement goals. Successfully grew and exited from a $300 million health care service and IT business in 2002.Specialties: Strategy, Innovation, Business Development, Corporate Development, Health Care, Technology, Venture Capital, Private Equity, and Mergers and Acquisitions.